Case #75: Microcystic Macular Edema Secondary to Optic Atrophy

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 29 of 29

About the Author Eric R. Devore, OD, FAAO, Diplomate ABO, is a graduate of SUNY State College of Optometry. He completed advanced residency training in the management of ocular disease and perioperative care with OMNI Eye Services NJ before transitioning to the role of Center Director of OMNI Eye Surgery

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 29 of 292025-05-30T14:49:05+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 28 of 29

About the Author Dr. Diana Doscas graduated from SUNY College of Optometry in 2023.  She completed her residency training in primary care optometry and ocular disease at VA Hudson Valley and is currently employed at a private practice in White Plains, NY.

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 28 of 292025-06-04T15:08:20+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 27 of 29

References: Sriram P, Graham SL, Wang C, et al. Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study. Invest Ophthalmol Vis Sci 2012;53:1271–5. Gills JP Jr, Wadsworth JA. Degeneration of the inner nuclear layer of the retina following lesions of the optic nerve. Trans Am Ophthalmol Soc 1966;64:66–88.

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 27 of 292025-05-30T14:39:39+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 26 of 29

Clinical Takeaways: The detection of MME has important prognostic and therapeutic implicationsThe presence of microcysts has been associated with a poor long-term functional outcome in patients with MS and ARMD compared to those without MMEMicrocystic changes are most frequently observed in ARMD, post-op after vitrectomy and CE, and in ERMsThe percentage

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 26 of 292025-05-30T14:39:50+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 25 of 29

Back to the Case: Why did the patient present with worsening symptoms? All patients have a decrease in ganglion cells as they age; however, there is enough of a reserve that it does not significantly affect visual function in healthy patients Normal loss is ~0.6% per year If you suffer

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 25 of 292025-05-30T14:40:26+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 23 of 29

Support of a Retrograde Process: Prolonged time course to onset of MMEMME 6.5-6.8 years following diagnosis of optic neuropathyMME respects topographic distribution of RNFLReduced thickness of NFL and ganglion cell layer in areas affected by MME

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 23 of 292025-05-30T14:40:57+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 22 of 29

Pathophysiology: Retrograde trans-synpatic degeneration from optic neuropathy causes degeneration of the INL with formation of cystic spaces Muller cells transverse through the entire retina with the bulk of their cell body in the INL Muller cells maintain homeostasis of the retina, support neuronal activity, and regulate the blood retinal barrier

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 22 of 292025-05-30T14:47:33+00:00

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 20 of 29

Diagnosis: Microcystic Macular Edema MME has also been described in compressive optic neuropathy, Leber’s heredity optic neuropathy, and dominant optic atrophy MME not dependent on site of optic nerve damage Not restricted to neurologic etiologies- has been described in ARMD, idiopathic juxtafoveal retinal telangiectasis, and tamoxifen retinopathy Muller cell dysfunction

Case #75: Microcystic Macular Edema Secondary to Optic Atrophy – Page 20 of 292025-05-30T14:46:49+00:00